4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-064272
EVP, Chief R&D Officer gave up 4,086 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Friberg Gregory R · EVP, Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-30 | Shares withheld for taxes : show line 1 in the form | −4,086 | $60.00 | $245,160 | 47,732 | D |
Loading xslF345X06/wk-form4_1790886185.xml…